-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Targeting Metabolic Deregulation in Acute Myeloid Leukemia

Program: Scientific Program
Session: Metabolic Deregulation in Hematopoietic Neoplasia: Tumor, The Environment, and Therapies.
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Combination therapy, Apoptosis, Translational Research, Drug development, Treatment Considerations, Metabolism, Biological Processes, Molecular biology
Sunday, December 8, 2024, 9:30 AM-10:45 AM

Paolo Gallipoli, MD

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Disclosures: Gallipoli: Astellas: Honoraria; GSK: Other: Spouse works for GSK.

See more of: Metabolic Deregulation in Hematopoietic Neoplasia: Tumor, The Environment, and Therapies.
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>